Social cognition in patients with schizophrenia

被引:0
|
作者
Hajduk, Michal [1 ,2 ]
Heretik, Anton [1 ]
Zimanyiova, Miroslava [2 ]
Krajcovicova, Dana [2 ]
Korinkova, Viera [2 ]
Pecenak, Jan [2 ]
机构
[1] Univ Komenskeho, Filozoficka Fak, Katedra Psychol, Gondova 2, Bratislava 81499, Slovakia
[2] Univ Komenskeho UNB, Psychiat Klin, Lekarskej Fak, Bratislava, Slovakia
来源
CESKOSLOVENSKA PSYCHOLOGIE | 2018年 / 62卷 / 02期
关键词
social cognition; methods; neurocognition; functional outcome; FACIAL AFFECT RECOGNITION; EMOTION RECOGNITION; NEUROCOGNITIVE DEFICITS; NEGATIVE SYMPTOMS; HIGH-RISK; MIND; PEOPLE; PERCEPTION; MEDIATOR; SYMPTOMATOLOGY;
D O I
暂无
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The authors are dealing with the topic of social cognition and its deficits in patients with schizophrenia. In the introduction they define social cognition and describe its domains that constitute two broad factors, socio-cognitive abilities and socio-cognitive biases. For each domain of social cognition they quantify the severity of deficit, its relationship to clinical characteristics of the disorder, symptomatology and neurocognition. In the conclusion the authors describe the relationships between social cognition, neurocognition and functional outcome. According to the current empirical evidence, social cognition acts as a mediator of relationship between neurocognition and functional outcome. Ability to process properly social stimuli is associated with better every day functioning of patients and thus should represent a potential target for further interventions.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 50 条
  • [21] The effectiveness of the social cognition intervention among the patients with schizophrenia
    Abdeltawab, Al-shymaa M.
    Khali, Enayat A.
    Osman, Zeinab A.
    Abdelsalam, Zeinab M.
    Hussien, Aya M.
    Rakhawy, Mona Y.
    [J]. BIOSCIENCE RESEARCH, 2018, 15 (03): : 2507 - 2519
  • [22] Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
    Kucharska-Pietura, Katarzyna
    Mortimer, Ann
    [J]. CNS DRUGS, 2013, 27 (05) : 335 - 343
  • [23] Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
    Katarzyna Kucharska-Pietura
    Ann Mortimer
    [J]. CNS Drugs, 2013, 27 : 335 - 343
  • [24] Neurocognition, social cognition and functional outcomes of schizophrenia patients
    Lee, S.
    Kim, S. H.
    Chung, Y. C.
    Park, Y. M.
    Kim, J. N.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 594 - 594
  • [25] The effect of perospirone on impairment of social cognition in patients with schizophrenia
    Higuchi, Yuko
    Sumiyoshi, Tomiki
    Kawasaki, Yasuhiro
    Ito, Toru
    Matsui, Mie
    Arai, Hirofumi
    Kurachi, Masayoshi
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : A5 - A5
  • [26] Social cognition in schizophrenia patients and their siblings: the role of insula
    Caldiroli, A.
    Buoli, M.
    Van Haren, N.
    De Nijs, J.
    Altamura, A. C.
    Cahn, W.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S695 - S696
  • [27] The Influence of Social Cognition on Ego Disturbances in Patients with Schizophrenia
    Schimansky, Jenny
    Roessler, Wulf
    Haker, Helene
    [J]. PSYCHOPATHOLOGY, 2012, 45 (02) : 117 - 125
  • [28] Mismatch Negativity, Social Cognition, and Functioning in Schizophrenia Patients
    Wynn, Jonathan K.
    Sugar, Catherine
    Horan, William P.
    Kern, Robert
    Green, Michael F.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 940 - 947
  • [29] Cognition and Schizophrenia: From Neurocognition to Social Cognition
    Rodriguez-Jimenez, Roberto
    Fernandez-Garcimartin, Helena
    Bagney, Alexandra
    Dompablo, Monica
    Torio, Iosune
    Rodriguez, Cilia
    Arias Horcajadas, Francisco
    Rodriguez-Torresano, Javier
    [J]. PSILOGOS, 2013, 11 (01) : 10 - 24
  • [30] The Dynamic Social Cognition Scale (DSCB): A Novel Scale for Assessing Domains of Social Cognition in Patients with Schizophrenia
    Opler, MArk
    Khan, Anzalee
    Rothman, Brian
    Lucic, Luka
    Yavorsky, Christian
    White, Jacob
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 271S - 271S